Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137306 · ClinicalTrials.gov registry record · Phase 4
Facilitating the Adoption of Evidence-Based Depression Management in Substance Use Treatment Programs
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT00137306 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 300 participants.
The verdict
NCT00137306, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
Comorbid depression has been consistently linked to worse outcomes for patients in substance abuse treatment programs. Practice guidelines recommend pharmacotherapy for comorbid depression if symptoms persist after a 4-week "wash-out" period for detoxification (e.g., Veterans Health Administration; American Psychiatric Association). Medications may be considered earlier if a patient has current symptoms and a history of major depressive disorder (MDD) during periods of sobriety. Current efficacy data suggest that antidepressant medication can improve both depression and substance use outcomes among comorbid patients Guideline-concordant use of antidepressant medication for persons with comorbid substance use and depressive disorders, however, is not routine in many VA substance abuse treatment settings.
Interventions
- PROCEDURE Facilitate evidence-based treatment for depression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00137306
The ClinicalTrials.gov registry entry for NCT00137306 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Facilitate evidence-based treatment for depression is the first listed.
NCT00137306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00137306 about?
NCT00137306 is a clinical study titled "Facilitating the Adoption of Evidence-Based Depression Management in Substance Use Treatment Programs". Comorbid depression has been consistently linked to worse outcomes for patients in substance abuse treatment programs. Practice guidelines recommend pharmacotherapy for comorbid depression if symptoms persist after a 4-week "wash-out" period for detoxification (e.g., Veterans Health Administration; ...
What is the current status of trial NCT00137306?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2004-01. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00137306?
The interventions under investigation include: Facilitate evidence-based treatment for depression (PROCEDURE).
Who is sponsoring clinical trial NCT00137306?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.